CY1108962T1 - Συνθεση μεταμεριδιου - Google Patents

Συνθεση μεταμεριδιου

Info

Publication number
CY1108962T1
CY1108962T1 CY20091100390T CY091100390T CY1108962T1 CY 1108962 T1 CY1108962 T1 CY 1108962T1 CY 20091100390 T CY20091100390 T CY 20091100390T CY 091100390 T CY091100390 T CY 091100390T CY 1108962 T1 CY1108962 T1 CY 1108962T1
Authority
CY
Cyprus
Prior art keywords
nucleic acid
protein
discontinuous
segment
molecule
Prior art date
Application number
CY20091100390T
Other languages
English (en)
Inventor
Wouter Cornelis Puijk
Jelle Wouter Slootstra
Dijk Evert Van
Original Assignee
Pepscan Systems B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepscan Systems B.V. filed Critical Pepscan Systems B.V.
Publication of CY1108962T1 publication Critical patent/CY1108962T1/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/08Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Structural Engineering (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Prostheses (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)

Abstract

Η ευρεσιτεχνία σχετίζεται με το πεδίον της μοριακής αναγνώρισης ή ανίχνευσης των ασυνεχών περιοχών πρόσδεσης ή επιτόπων ή των περιοχών πρόσδεσης ή επιτόπων διαμόρφωσης, που αντιστοιχούν σε ένα μόριο πρόσδεσης, ιδιαίτερα σε σχέση με τις αλληλεπιδράσεις πρωτεΐνη-πρωτεΐνη πρωτεΐνη-νουκλεϊκό οξύ, νουκλεϊκό οξύ-νουκλεϊκό οξύ ή βιομόριο-προσδέτης. Η ευρεσιτεχνία παρέχει μία συνθετική μοριακή βιβλιοθήκη επιτρέποντας την δοκιμασία για ταυτοποίηση, χαρακτηρισμό ή ανίχνευση μίας ασυνεχούς περιοχής πρόσδεσης ικανής να αλληλεπιδρά με ένα μόριο πρόσδεσης, η εν λόγω βιβλιοθήκη έχει παρασχεθεί με ένα πλήθος μορίων, έκαστο μόριο των εν λόγω μορίων περιλαμβάνει τουλάχιστον ένα πρώτο μεταμερίδιο, το οποίο συνδέεται με ένα δεύτερο μεταμερίδιο, έκαστο μεταμερίδιο που έχει την ικανότητα να είναι ένα δυνητικό μονό τμήμα μίας ασυνεχούς περιοχής πρόσδεσης.
CY20091100390T 2000-02-16 2009-04-02 Συνθεση μεταμεριδιου CY1108962T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200536A EP1125905A1 (en) 2000-02-16 2000-02-16 Segment synthesis
EP01908463A EP1255716B1 (en) 2000-02-16 2001-02-16 Segment synthesis

Publications (1)

Publication Number Publication Date
CY1108962T1 true CY1108962T1 (el) 2014-07-02

Family

ID=8171031

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100390T CY1108962T1 (el) 2000-02-16 2009-04-02 Συνθεση μεταμεριδιου

Country Status (14)

Country Link
US (2) US20040110224A1 (el)
EP (2) EP1125905A1 (el)
JP (1) JP2003522961A (el)
AT (1) ATE420226T1 (el)
AU (2) AU3620501A (el)
CA (1) CA2400338C (el)
CY (1) CY1108962T1 (el)
DE (1) DE60137311D1 (el)
DK (1) DK1255716T3 (el)
ES (1) ES2321477T3 (el)
IL (2) IL151184A0 (el)
NZ (1) NZ520698A (el)
PT (1) PT1255716E (el)
WO (1) WO2001060769A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
ES2744275T3 (es) 2002-10-17 2020-02-24 Genmab As Anticuerpos monoclonales humanos contra CD20 para su uso en el tratamiento de esclerosis múltiple
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
KR101401159B1 (ko) 2005-12-12 2014-05-29 에프. 호프만-라 로슈 아게 가변 부위에 글리코실화를 가지는 아밀로이드 베타에 대한 항체
US8772236B2 (en) 2009-02-06 2014-07-08 Pepscan Systems B.V. Truncated cystine-knot proteins
MX346475B (es) 2011-01-06 2017-03-22 Bionor Immuno As Peptidos inmunogenicos monomericos y multimericos.
BR112017024610A2 (pt) 2015-06-24 2018-07-31 F. Hoffmann-La Roche Ag anticorpos para receptor antitransferrina com afinidade especificada
KR20220131277A (ko) 2015-09-01 2022-09-27 아게누스 인코포레이티드 항-pd-1 항체 및 이를 이용하는 방법
RU2753390C1 (ru) 2015-10-02 2021-08-13 Ф. Хоффманн-Ля Рош Аг Биспецифические антитела к человеческому cd20/человеческому рецептору трансферрина и способы их применения
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
MA45123A (fr) 2016-05-27 2019-04-10 Agenus Inc Anticorps anti-tim-3 et leurs méthodes d'utilisation
CN110023337B (zh) 2016-10-11 2024-01-05 艾吉纳斯公司 抗lag-3抗体及其使用方法
AU2017373944B2 (en) 2016-12-07 2022-02-03 Agenus Inc. Anti-CTLA-4 antibodies and methods of use thereof
WO2018157048A1 (en) 2017-02-24 2018-08-30 Massachusetts Institute Of Technology Methods for examining podocyte foot processes in human renal samples using conventional optical microscopy
BR112019017241A2 (pt) 2017-04-13 2020-04-14 Agenus Inc anticorpos anti-cd137 e métodos de uso dos mesmos
EP3618863B1 (en) 2017-05-01 2023-07-26 Agenus Inc. Anti-tigit antibodies and methods of use thereof
WO2019156957A1 (en) 2018-02-06 2019-08-15 Massachusetts Institute Of Technology Swellable and structurally homogenous hydrogels and methods of use thereof
WO2021042019A1 (en) 2019-08-30 2021-03-04 Agenus Inc. Anti-cd96 antibodies and methods of use thereof
WO2021113505A1 (en) 2019-12-05 2021-06-10 Massachusetts Institute Of Technology Method for preparing a specimen for expansion microscopy
CN117980319A (zh) * 2021-09-22 2024-05-03 麻省理工学院 单分子蛋白质和肽测序

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923772A (en) * 1970-03-16 1975-12-02 Shionogi & Co (1-{60 -aminoisobutyric acid)-corticotropin peptides
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4931223A (en) * 1986-07-24 1990-06-05 Tropix, Inc. Methods of using chemiluminescent 1,2-dioxetanes
US6291158B1 (en) * 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
US5368712A (en) * 1989-11-02 1994-11-29 Synporin Technologies, Inc. Biologically mimetic synthetic ion channel transducers
DE4027675C2 (de) * 1990-08-31 1997-05-07 Biotechnolog Forschung Gmbh Verfahren zur parallelen Herstellung von trägergebundenen oder freien Peptiden, trägergebundene Peptide und ihre Verwendung
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
EP0557456A4 (en) * 1990-11-14 1995-11-15 Siska Diagnostics Inc Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor
US5208148A (en) * 1990-12-07 1993-05-04 Molecular Probes, Inc. Lipophilic fluorescent glycosidase substrates
JPH07501929A (ja) * 1991-08-23 1995-03-02 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴマーフラグメントの合成非ランダム化
US6310180B1 (en) * 1993-06-21 2001-10-30 Vanderbilt University Method for synthesis of proteins
US5824483A (en) * 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
AU3719395A (en) * 1994-09-21 1996-04-09 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US5885577A (en) * 1994-09-21 1999-03-23 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US5629179A (en) * 1995-03-17 1997-05-13 Novagen, Inc. Method and kit for making CDNA library
JP2947729B2 (ja) * 1995-07-06 1999-09-13 科学技術振興事業団 脂質単分子膜によるペプチド認識方法
CA2270394A1 (en) * 1996-10-31 1998-05-07 Novalon Pharmaceutical Corporation Identification of drugs using complementary combinatorial libraries
DE19703801A1 (de) * 1997-02-01 1998-08-06 Boehringer Ingelheim Kg Neue Dipeptidtemplate, Verfahren zu deren Herstellung und deren Verwendung zum Einbau in Peptidsequenzen, unter anderem auf Gebiet der kombinatorischen Chemie
US20020068301A1 (en) * 1997-05-28 2002-06-06 Hung-Sen Lai Cyclic peptide libraries and methods of use thereof to identify binding motifs
CA2301846A1 (en) * 1997-09-04 1999-03-11 Gryphon Sciences Modular protein libraries and methods of preparation
DE19741716A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Adressierbares modulares Erkennungssystem, seine Herstellung und Verwendung
US6461812B2 (en) * 1998-09-09 2002-10-08 Agilent Technologies, Inc. Method and multiple reservoir apparatus for fabrication of biomolecular arrays
US6852696B2 (en) * 1999-03-26 2005-02-08 The University Of Texas System Inhibitors of glycosaminoglycans
WO2008013454A2 (en) * 2006-07-26 2008-01-31 Pepscan Systems B.V. Immunogenic compounds and protein mimics

Also Published As

Publication number Publication date
WO2001060769A1 (en) 2001-08-23
IL151184A0 (en) 2003-04-10
PT1255716E (pt) 2009-04-03
US20080139407A1 (en) 2008-06-12
ATE420226T1 (de) 2009-01-15
JP2003522961A (ja) 2003-07-29
EP1125905A1 (en) 2001-08-22
EP1255716A1 (en) 2002-11-13
EP1255716B1 (en) 2009-01-07
CA2400338A1 (en) 2001-08-23
AU3620501A (en) 2001-08-27
AU2001236205B2 (en) 2006-08-24
DK1255716T3 (da) 2009-04-20
DE60137311D1 (en) 2009-02-26
NZ520698A (en) 2004-03-26
CA2400338C (en) 2011-11-01
IL151184A (en) 2010-11-30
US20040110224A1 (en) 2004-06-10
ES2321477T3 (es) 2009-06-08

Similar Documents

Publication Publication Date Title
CY1108962T1 (el) Συνθεση μεταμεριδιου
DE60136202D1 (de) Bestimmung von protein-bindungsstellen
ATE513218T1 (de) Verfahren zur auswahl von kandidat- drogenverbindungen
ATE425186T1 (de) Synthetische immunoglobulindomänen mit in regionen des moleküls, die sich von den die komplementarität bestimmenden bereichen unterscheiden, modifizierten bindeeigenschaften
DE60234131D1 (de) Neue fusionsproteine und molekulare bindungsassays
Favalli et al. A DNA‐Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
ATE441711T1 (de) Peptide fähig die dimerisierung von c-jun zu inhibieren
WO2001094617A3 (en) Protein fragment complementation assay based on beta-lactamase
DE69628194D1 (de) Verfahren zum nachweis von verbindungen die bestimmte zielmoleküle binden
CY1107474T1 (el) Χρηση 13c-nmr για να ανιχνευεται συνδεση
WO2003002724A3 (en) Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics
ATE393394T1 (de) Verfahren zum nachweis von proteinen, die miteinander interagieren
WO2003010536A3 (en) Tnf-alpha mimics and lead optimisation
DK1224486T3 (da) Anvendelse af dobbeltkvantum-1H-NMR-spektroskopi til identifikation af ligander, der interagerer med malbiomolekyler
DE50201535D1 (de) Betätigungsvorrichtung für Entriegelungseinrichtungen von Fahrzeugen, vorzugsweise von Kraftfahrzeugen
DE69405989D1 (de) Hippurikasegen
DE50113417D1 (de) Zellbindende nukleinsäuremoleküle (aptamere)
DE29901691U1 (de) Anordnung zum Sichern von Garagenvorplätzen
BR0006627B1 (pt) processo de pavimentação asfáltica de baixo custo.
DK1266008T3 (da) Akut neuroninduceret calciumbindende protein type 1-ligand